Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary

6. Endocrine system Guidelines



BNSSG Blood Glucose Management in Type 2 Diabetes

BNSSG Quick Reference Guide for Selecting Glucose Therapy during GLP1 RA Supply Shortage

BNSSG Advice for Patients Stopping GLP1s Leaflet

BNSSG GLP-1 Stock Shortage Patient Information Leaflet

BNSSG GLP-1 Information Summary for Clinicians 

Blood Glucose Monitoring

Clinical Pathway for the use of diabetes technologies in all patients with Type 1 Diabetes

BNSSG Type 1 Blood Glucose Monitoring Guidance (Primary Care)

BNSSG Type 2 Diabetes Blood Glucose Monitoring Guidance (Adults)

Information on Continuous Glucose Monitoring (CGM) in Type 1 Diabetes for Primary Care which includes information on GlucoRx Aidex, Dexcom One, Glucomen Day, Freestyle Libre 2


BNSSG Pen Needles Guidance

SGLT-2 inhibitors

Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease


When to start Osteoporosis Treatment 2022 minor amendment

Osteoporosis - oral treatment duration, denosumab and drug holiday guidance 2021

BNSSG Osteoporosis Clinic Referral Guidance for GPs 2021

Bisphosphonate Drug Holiday Algorithm June 2021

Denosumab Drug Holiday Algorithm June 2021


Hormone Therapy for Gender Reassignment

Local Guidance

Guidance from Gender Identity Clinics (GIC) Clinics 



BNSSG Menopause Guidelines and HRT Prescribing Pathway (updated July 2022)



Guidance on issuing the Steroid Emergency Card in adults

BNSSG Tool on Implementing the NPSA alert on the Emergency steroid card

For information regarding provision of a Steroid Emergency card for paediatrics, please see Paediatric Chapter 6.2 for further details 


Sick Day Rules

For BNSSG Sick Day Rules Guideline see Other Guideline page